Alzheimer’s disease (AD) is the most common age-related neurodegenerative disorder affecting over 50 million people worldwide (Hickman et al., 2016; Patterson, 2018). With no cure and limited options for early unambiguous and noninvasive diagnosis, this devastating and invariably fatal disease remains a major medical, sociological and economical challenge around the globe (Patterson, 2018; Alzheimer’s Association, 2019).